Menopause doesn't create
the problem. It lifts the veil.

🩺 1. Name the terrain before treating symptoms

• Inform your doctor of the PMCHS/MCAS context before discussing menopause. What you are experiencing is not an"ordinary" menopause — standard treatment may not be sufficient.
• Request a histamine workup: 24-hour urinary histamine (ideally off antihistamines), serum tryptase. These markers help objectify the terrain at the time of the menopausal assessment.
• Keep a hot flush diary noting dietary, emotional and thermal triggers. You will quickly observe that your flushes are not random — they follow identifiable histamine patterns.

⚗️ 2. Hormone therapy — what the PMCHS terrain changes

• Bio-identical micronised progesterone (Utrogestan) is preferable to synthetic progestogens. It has a mast cell stabilising effect that synthetic progestogens do not replicate — and some of them may even worsen the terrain.
• Transdermal oestrogens (gel or patch) bypass hepatic first-pass and generate fewer blood-level fluctuations than oral administration — which can cause iatrogenic histamine spikes.
• Start low, go slow. On the PMCHS terrain, introducing hormone therapy can itself trigger reactions in the first weeks (ERα activation). The usual escalation can be managed by very gradual titration.
• Wait 6 to 8 weeks before evaluating the real efficacy of hormone therapy. The mast cell terrain takes time to stabilise after hormonal re-introduction.

🌿 3. Mast cell stabilisation — menopausal priorities

• H1 antihistamine in the evening (e.g. cetirizine): particularly effective against nocturnal histamine wake-ups, nocturnal hot flushes and stubborn insomnia. To be validated with your doctor.
• Quercetin and luteolin: natural mast cell stabilisers to reinforce at menopause. Quercetin also inhibits androgen-to-oestrogen conversion by aromatase — useful if PCOS is co-present.
• PEA (palmitoylethanolamide): via PPAR-α, reduces neuroinflammation and central sensitisation worsened by hormonal decline. Particularly indicated if diffuse pain, brain fog or fibromyalgia co-exist.
• Magnesium L-threonate (morning): menopausal brain fog × mast cell neuroinflammation = double load on working memory. Mg-threonate crosses the blood-brain barrier and specifically targets this mechanism.
• Strengthened DHA omega-3: oestrogen decline reduces cerebral DHA synthesis. 2–3 g/day minimum, triglyceride form. Documented effects on menopausal depression, neuroinflammation and hot flushes.

🥗 4. Diet — menopause-specific adjustments

• Phytoestrogens with caution: soy isoflavones bind to ERβ (mast cell brake) — potentially beneficial on PMCHS terrain. But high consumption can amplify the ERα loop in some women. Prefer red clover (rich in formononetin) to soy if reactions occur after consumption.
• Further reduce fermented foods and histamine releasers: without progesterone modulation, your histamine threshold is lower than during your reproductive years. What was tolerable may no longer be.
• Prioritise tryptophan-rich foods: turkey, pumpkin seeds, eggs, brown rice. Tryptophan → serotonin → melatonin conversion is impaired on menopausal neuroinflammatory terrain — supporting it through diet helps sleep onset.

🧘 5. Nervous system — enhanced regulation at menopause

The hormonal drop worsens the sympathetic dominance already present in the PMCHS terrain. Autonomic regulation work becomes an absolute priority — not as a"wellness" tool but as a direct anti-inflammatory intervention.

• Cardiac coherence 3× daily without exception: at menopause, the cumulative effect on the vagus nerve is even more important. HRV (heart rate variability) is often very low — its improvement is the first treatment response biomarker.
• EMDR or somatic therapy if PTSD is co-present: menopause often reactivates old traumas via the same neuroinflammatory mechanism. This is not purely psychological in the ordinary sense — it is a biological reactivation.